HBV Vaccination Status and Response to Hepatitis B Vaccine Among Iranian Dentists, Correlation With Risk Factors and Preventive Measures

Authors Information
Article Notes and Dates
To Cite : Momeni N, Ahmad Akhoundi M S, Alavian S M, Shamshiri A R, Norouzi M, et al. HBV Vaccination Status and Response to Hepatitis B Vaccine Among Iranian Dentists, Correlation With Risk Factors and Preventive Measures, Hepat Mon. 2015 ;15(1):e20014. doi: 10.5812/hepatmon.20014.
Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Shah SM, Merchant AT, Dosman JA. Percutaneous injuries among dental professionals in Washington State. BMC Public Health. 2006; 6: 269[DOI][PubMed]
  • 2. Vadivale M, Tan TC, Ong CN. Sero-prevalence of hepatitis B infection among dental professionals. Singapore Med J. 1992; 33(4): 367-9[PubMed]
  • 3. Song KB, Choi KS, Lang WP, Jacobson JJ. Hepatitis B prevalence and infection control among dental health care workers in a community in South Korea. J Public Health Dent. 1999; 59(1): 39-43[PubMed]
  • 4. Reingold AL, Kane MA, Hightower AW. Failure of gloves and other protective devices to prevent transmission of hepatitis B virus to oral surgeons. JAMA. 1988; 259(17): 2558-60[PubMed]
  • 5. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med. 1996; 100(1): 41-5[PubMed]
  • 6. Mahboobi N, Agha-Hosseini F, Safari S, Lavanchy D, Alavian SM. Hepatitis B virus infection in dentistry: a forgotten topic. J Viral Hepat. 2010; 17(5): 307-16[DOI][PubMed]
  • 7. Hofmann F, Kralj N. Criteria for successful hepatitis B vaccination in adults: results of a case study. Infection. 2009; 37(3): 266-9[DOI][PubMed]
  • 8. Ammon A, Reichart PA, Pauli G, Petersen LR. Hepatitis B and C among Berlin dental personnel: incidence, risk factors, and effectiveness of barrier prevention measures. Epidemiol Infect. 2000; 125(2): 407-13[PubMed]
  • 9. Batista SM, Andreasi MS, Borges AM, Lindenberg AS, Silva AL, Fernandes TD, et al. Seropositivity for hepatitis B virus, vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil. Mem Inst Oswaldo Cruz. 2006; 101(3): 263-7[PubMed]
  • 10. Cleveland JL, Siew C, Lockwood SA, Gruninger SE, Gooch BF, Shapiro CN. Hepatitis B vaccination and infection among U.S. dentists, 1983-1992. J Am Dent Assoc. 1996; 127(9): 1385-90[PubMed]
  • 11. Alavian SM, Akbari H, Ahmadzad-Asl M, Kazem M, Davoudi A, Tavangar H. Concerns regarding dentists' compliance in hepatitis B vaccination and infection control. Am J Infect Control. 2005; 33(7): 428-9[DOI][PubMed]
  • 12. Alavian SM, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011; 11(2): 99-102[PubMed]
  • 13. Alavian SM, Mahboobi N, Savadrudbari MM, Azar PS, Daneshvar S. Iranian dental students' knowledge of hepatitis B virus infection and its control practices. J Dent Educ. 2011; 75(12): 1627-34[PubMed]
  • 14. Alavian SM, Izadi M, Zare AA, Lankarani MM, Assari S, Vardi MM. Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists. Spec Care Dentist. 2008; 28(6): 265-70[DOI][PubMed]
  • 15. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005; 142(5): 333-41[PubMed]
  • 16. Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J Immunol. 1995; 154(2): 520-9[PubMed]
  • 17. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J. 2008; 27(10): 881-5[DOI][PubMed]
  • 18. Valats JC, Tuaillon E, Funakoshi N, Hoa D, Brabet MC, Bollore K, et al. Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination. Vaccine. 2010; 28(39): 6411-6[DOI][PubMed]
  • 19. Williams JL, Christensen CJ, McMahon BJ, Bulkow LR, Cagle HH, Mayers JS, et al. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine. 2001; 19(28-29): 4081-5[PubMed]
  • 20. Milich DR, Leroux-Roels GG. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev. 2003; 2(5): 248-57[PubMed]
  • 21. Hohler T, Stradmann-Bellinghausen B, Starke R, Sanger R, Victor A, Rittner C, et al. C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol. 2002; 37(3): 387-92[PubMed]
  • 22. Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev. 2005; (4)[DOI][PubMed]
  • 23. Alimonos K, Nafziger AN, Murray J, Bertino JS, Jr.. Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness? Clin Infect Dis. 1998; 26(3): 566-71[PubMed]
  • 24. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005; 118 Suppl 10A: 34S-9S[DOI][PubMed]
  • 25. Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ. 1997; 314(7077): 329-33[PubMed]
  • 26. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. 1998; 15(1): 1-8[PubMed]
  • 27. Propst T, Propst A, Lhotta K, Vogel W, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis. 1998; 32(6): 1041-5[PubMed]
  • 28. Raz R, Koren R, Bass D. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults. Isr Med Assoc J. 2001; 3(5): 328-32[PubMed]
  • 29. Yap I, Guan R, Chan SH. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity. Vaccine. 1992; 10(7): 439-42[PubMed]
  • 30. John M. Hepatitis B immunization and postimmunization serology. J Can Dent Assoc. 2000; 66(10): 551-2[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check